A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain (NCT07641517)
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY4065967 for the Treatment of Osteoarthritis
🩺 Plain-English Summary (8th-Grade Level)
The main purpose of this study is to test the safety and efficacy of study drug for the treatment of knee pain due to osteoarthritis (OA). This trial is part of the chronic pain master protocol H0P-MC-CPMP (NCT05986292), which is a protocol to accelerate the development of new treatments for chronic pain.
Who can join: Review the eligibility criteria below.
Location: Central Research Associates — Birmingham, Alabama
Age range: 40 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (37 Sites)
Showing the first 25 of 37 sites.
- Central Research Associates — Birmingham, Alabama
- Synexus Clinical Research US, Inc. — Phoenix, Arizona
- Arizona Research Center — Phoenix, Arizona
- Desert Oasis Healthcare Medical Group — Palm Springs, California
- Artemis Institute for Clinical Research — Riverside, California
- Artemis Institute for Clinical Research — San Diego, California
- CMR of Greater New Haven — Hamden, Connecticut
- Bradenton Research Center, Inc. — Bradenton, Florida
- Accel Research Sites - DeLand Clinical Research Unit — DeLand, Florida
- K2 MEDICAL Research THE VILLAGES — Lady Lake, Florida
- K2 Medical Research ORLANDO — Maitland, Florida
- Merritt Island Medical Research, LLC — Merritt Island, Florida
- Suncoast Research Group — Miami, Florida
- New Horizon Research Center — Miami, Florida
- Suncoast Clinical Research, Inc. — New Port Richey, Florida
- Renstar Medical Research — Ocala, Florida
- Precision Clinical Research — Sunrise, Florida
- Charter Research - Lady Lake — The Villages, Florida
- Conquest Research — Winter Park, Florida
- North Georgia Clinical Research — Woodstock, Georgia
- Northwestern University — Chicago, Illinois
- DelRicht Research — New Orleans, Louisiana
- Lucida Clinical Trials — New Bedford, Massachusetts
- MedVadis Research Corporation — Waltham, Massachusetts
- Great Lakes Research Group, Inc. — Bay City, Michigan
📞 Contact the Study Coordinator
Phone: (317) 615-4559
Email: LillyTrials@Lilly.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Osteoarthritis, Knee
- The Impact of Procedural Awareness of Knee Injections for Osteoarthritis on Patient Perceptions of Effectiveness — Hamilton, Ontario
- Genicular Radiofrequency Ablation Following Total Knee Arthroplasty — Calgary, Alberta
- Autologous Adipose-derived Stromal Vascular Fraction for Treatment of Knee Osteoarthritis — Sacramento, California
- Treatment Effects of Subcutaneous Injections of Pentosan Polysulfate Sodium vs Placebo in Participants With Knee OA Pain — Tempe, Arizona
- Prospective Randomized Study of Cementless vs Cemented UKA — New Albany, Ohio
- Clinical Outcomes of Joint Arthroplasty — St. Helena, California
Explore by condition: All Osteoarthritis, Knee clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.